Use of (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro - 2,6-dymethyl-pyridine-3,5-dicarboxylate in the treatment of memory disorders

Details for Australian Patent Application No. 2004292967 (hide)

Owner Memory Pharmaceuticals Corporation

Inventors De Vivo, Michael; Unterbeck, Axel; Rose, Gregory M.

Agent Cullen & Co

Pub. Number AU-A-2004292967

PCT Pub. Number WO2005/051389

Priority 60/523,664 21.11.03 US; 60/608,116 09.09.04 US

Filing date 19 November 2004

Wipo publication date 9 June 2005

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4422 (2006.01) - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/4745 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

29 June 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Jun 2006

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051389 Priority application(s): WO2005/051389

17 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292973-Composition and method

2004292966-Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors